Table 4 Risks for glaucoma and macular degeneration in US radiologic technologists and other radiation-exposed cohorts.

From: Occupational radiation exposure and glaucoma and macular degeneration in the US radiologic technologists

Model

Dose (Gy), mean (range)

Cases

Excess relative risk (hazard ratio) /Gy

95% CI

Glaucoma

US radiologic technologists (current study, unadjusted for covariates)

0.058 (0–1.51)

1631

−1.39

(−1.94, −0.69)

US radiologic technologists (current study, adjusted for covariates)

−0.57

(−1.46, 0.60)

Japanese atomic-bomb survivors40

0.57 (0 − >4.14)

211

−0.18

(−0.20, −0.03)

Japanese atomic-bomb survivors19 – primary open-angle normal tension glaucoma (IOP ≤21 mmHg)

0.47 (0 − >3.01)

226

0.31

(0.11, 0.53)

Japanese atomic-bomb survivors19 – primary open-angle hypertensive glaucoma (IOP >21 mmHg)

36

−0.21

(−0.48, 0.21)

Japanese atomic-bomb survivors19 – primary angle-closure glaucoma

25

−0.46

(−0.71, 0.02)

Macular degeneration

US radiologic technologists (current study, unadjusted for covariates)

0.058 (0−1.51)

1331

0.73

(−0.01, 1.74)

US radiologic technologists (current study, adjusted for covariates)

0.32

(−0.32, 1.27)

Japanese atomic-bomb survivors: retinal degeneration20

NA (0 − >3.0)

55

0.42

(0.07, 0.88)

Japanese atomic-bomb survivors early age-related macular degeneration21

0.45 (0 − >2.0)

191

−0.07

(−0.25, 0.15)

Japanese atomic-bomb survivors late age-related macular degeneration21

6

−0.21

(−0.79, 1.94)

  1. Adjusted relative risks for the present study are evaluated using a Cox model with age as timescale, with stratification by sex, race and birth year (by decade <1900, 1900–1909, …, 1950–1959, ≥1960), and with adjustment to the baseline hazard for diabetes, body mass index (BMI), smoking status (current smoker/ex-smoker/never smoker, numbers of cigarettes/day, age stopped smoking), each ascertained at the baseline survey. For each endpoint (glaucoma, macular degeneration) follow-up is restricted to those persons eligible for study (no record of radiotherapy or disease at baseline, unambiguous status at end of follow-up (with both fact and year of diagnosis known) etc)(see Methods). IOP = intraocular pressure.